Immediate Impact
55 standout
Citing Papers
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
2024 Standout
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
2023 Standout
Works of David Miller being referenced
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma
2016
Obesity Educational Interventions in U.S. Medical Schools: A Systematic Review and Identified Gaps
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| David Miller | 189 | 326 | 213 | 225 | 68 | 1.2k | |
| Curtis Travers | 185 | 416 | 131 | 165 | 58 | 1.1k | |
| Cenker Eken | 128 | 347 | 111 | 265 | 74 | 1.2k | |
| Itai Shavit | 143 | 306 | 113 | 334 | 98 | 1.1k | |
| Patrick Sorkine | 134 | 204 | 94 | 235 | 56 | 1.1k | |
| Eugenie S. Heitmiller | 226 | 269 | 166 | 186 | 53 | 1.2k | |
| Ilan Keidan | 181 | 339 | 125 | 123 | 53 | 1.1k | |
| Amir Vardi | 477 | 294 | 110 | 267 | 81 | 1.4k | |
| David G. Nichols | 335 | 192 | 81 | 245 | 48 | 1.2k | |
| William Casey | 257 | 425 | 109 | 136 | 62 | 1.2k | |
| Peter Barnett | 87 | 333 | 75 | 166 | 47 | 1.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...